Assessing ovarian cancer risk when considering elective oophorectomy at the time of hysterectomy
- PMID: 21471855
- PMCID: PMC3781934
- DOI: 10.1097/AOG.0b013e318212fcb7
Assessing ovarian cancer risk when considering elective oophorectomy at the time of hysterectomy
Abstract
Objective: To develop a risk-factor score that may provide additional guidance to women and their physicians regarding elective bilateral salpingo-oophorectomy at the time of hysterectomy.
Methods: From a case-control study conducted from 1992 to 2008 in women residing in eastern Massachusetts or New Hampshire, we selected 1,098 women with invasive ovarian cancer (case group) and 1,363 for the control group who were older than 40 years and had neither hysterectomy nor a personal or family history of breast or ovarian cancer. Using logistic regression, we identified key risk factors and built a risk score. The score was separately assessed in 126 women in the case group and 156 in the control group with excluded prior hysterectomy to determine whether women who developed ovarian cancer could have been distinguished.
Results: Summing eight conditions found to be associated with ovarian cancer (Jewish ethnicity, less than 1 year of oral contraceptive use, nulliparity, no breastfeeding, no tubal ligation, painful periods or endometriosis, polycystic ovary syndrome or obesity, talc use), we created a five-level score. Assigning average risk to those with a score of 2, the odds ratios varied from 0.56 (95% confidence interval [CI] 0.42-0.74) for a score of 0-1 to 3.30 (95% CI 2.50-4.35) for a score of 5 or greater (P trend <.001). The risk score was higher for women who developed ovarian cancer after hysterectomy than those who did not (P=.01). Lifetime risks for ovarian cancer for a woman at age 40 years are changed from 1.2% with a 0-1 score to 6.6% with a score of 5 or higher.
Conclusion: We developed a risk-assessment tool that can quantify women's risk for ovarian cancer and should be validated in other data sets.
Comment in
-
Assessing ovarian cancer risk when considering elective oophorectomy at the time of hysterectomy.Obstet Gynecol. 2011 Aug;118(2 Pt 1):359. doi: 10.1097/AOG.0b013e3182263337. Obstet Gynecol. 2011. PMID: 21775859 No abstract available.
Similar articles
-
Ovarian cancer incidence and death in average-risk women undergoing bilateral salpingo-oophorectomy at benign hysterectomy.Am J Obstet Gynecol. 2022 Feb;226(2):220.e1-220.e26. doi: 10.1016/j.ajog.2021.09.020. Epub 2021 Sep 24. Am J Obstet Gynecol. 2022. PMID: 34563499
-
ACOG Committee Opinion No. 774 Summary: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.Obstet Gynecol. 2019 Apr;133(4):842-843. doi: 10.1097/AOG.0000000000003165. Obstet Gynecol. 2019. PMID: 30913193 Review.
-
Trends in bilateral salpingo-oophorectomy among Taiwanese women undergoing benign hysterectomy: a population-based, pooled, cross-sectional study.Menopause. 2015 Jul;22(7):765-72. doi: 10.1097/GME.0000000000000360. Menopause. 2015. PMID: 25387346
-
Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study.Int J Cancer. 2013 Nov 15;133(10):2415-21. doi: 10.1002/ijc.28249. Epub 2013 Jul 9. Int J Cancer. 2013. PMID: 23650079 Free PMC article.
-
Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement.Maturitas. 2017 Jun;100:86-91. doi: 10.1016/j.maturitas.2017.03.003. Epub 2017 Mar 15. Maturitas. 2017. PMID: 28389043 Review.
Cited by
-
Puerperal mastitis: a reproductive event of importance affecting anti-mucin antibody levels and ovarian cancer risk.Cancer Causes Control. 2013 Nov;24(11):1911-23. doi: 10.1007/s10552-013-0266-1. Epub 2013 Aug 8. Cancer Causes Control. 2013. PMID: 23925696 Free PMC article.
-
The Association between Endometriosis, Tubal Ligation, Hysterectomy and Epithelial Ovarian Cancer: Meta-Analyses.Int J Environ Res Public Health. 2016 Nov 14;13(11):1138. doi: 10.3390/ijerph13111138. Int J Environ Res Public Health. 2016. PMID: 27854255 Free PMC article.
-
Clinical implication for endometriosis associated with ovarian cancer.Gynecol Minim Invasive Ther. 2017 Oct-Dec;6(4):152-156. doi: 10.1016/j.gmit.2017.08.003. Epub 2017 Aug 30. Gynecol Minim Invasive Ther. 2017. PMID: 30254904 Free PMC article. Review.
-
Adverse childhood or adult experiences and risk of bilateral oophorectomy: a population-based case-control study.BMJ Open. 2017 Jun 7;7(5):e016045. doi: 10.1136/bmjopen-2017-016045. BMJ Open. 2017. PMID: 28592582 Free PMC article.
-
Predictors of residual disease after debulking surgery in advanced stage ovarian cancer.Front Oncol. 2023 Jan 24;13:1090092. doi: 10.3389/fonc.2023.1090092. eCollection 2023. Front Oncol. 2023. PMID: 36761962 Free PMC article.
References
-
- Keshavarz H, Hillis S, Kieke B, Marchbanks PA. Hysterectomy surveillance–United States, 1994–1999. MMWR CDC Surveill Summ. 2002;51:1–8. - PubMed
-
- Coukos G, Rubin SC. Prophylactic oophorectomy. Best Pract Res Clin Obstet Gynaecol. 2002;16:597–609. - PubMed
-
- Kontoravdis A, Kalogirou D, Antoniou G, Kontoravdis N, Karakitsos P, Zourlas PA. Prophylactic oophorectomy in ovarian cancer prevention. Int J Gynaecol Obstet. 1996;54:257–62. - PubMed
-
- Studd J. Does retention of the ovaries improve long-term survival after hysterectomy? Prophylactic oophorectomy. Climacteric. 2006;9:164–6. - PubMed
-
- Geary M, Geoghegan A, Foley M. Prevention of ovarian cancer: a survey of the practice of prophylactic oophorectomy by consultant gynaecologists in Ireland. Ir Med J. 1997;90:186–7. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases